pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts2026-11-23: 0 catalysts2026-11-24: 0 catalysts2026-11-25: 0 catalysts2026-11-26: 0 catalysts2026-11-27: 0 catalysts2026-11-28: 0 catalysts2026-11-29: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Mar 16, 2026

    12
    ›Mar 20, 2026grant164d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — New York University Clinical and Translational Science HubNew York University

    TR grant. $9,581,287. PI: Miriam Antoinette Bredella

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoYALE UNIVERSITY — Cilia disassembly and dysfunction in malformations of cortical development

    NS grant. $583,646. PI: Angelique Bordey

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoUNIVERSITY OF PENNSYLVANIA — Therapeutic editing for cardiovascular diseasesUniversity of Pennsylvania

    HL grant. $1,137,435. PI: Kiran Musunuru

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoWEILL MEDICAL COLL OF CORNELL UNIV — AYA Cohort to Enhance Survivorship in NYC (ACES-NYC)

    CA grant. $1,053,426. PI: Danielle Friedman

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoYALE UNIVERSITY — Impact of peripheral inflammation on microglia and neurons in aging

    AG grant. $746,160. PI: Emilia Favuzzi

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoEMORY UNIVERSITY — Mechanisms of angiotensin II signaling within intercalated cellsEmory University

    DK grant. $821,916. PI: SUSAN MARIE WALL

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoUNIVERSITY OF PENNSYLVANIA — Comparative Effectiveness Trial of Low Barrier Access to Preferred Firearm Se...University of Pennsylvania

    NR grant. $732,795. PI: Mucio Delgado

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoBRIGHAM AND WOMEN'S HOSPITAL — Technology development center for integrative physiologic models of the human...Brigham and Women's Hospital

    TR grant. $3,516,688. PI: April Marie Craft

    full page →nih reporter ↗
    ›Mar 20, 2026grant164d agoMAYO CLINIC ROCHESTER — Blood-based tumor and immune markers for risk stratification and monitoring t...Mayo Clinic

    CA grant. $667,710. PI: Aadel Chaudhuri

    full page →nih reporter ↗
    ›Mar 21, 2026grant163d agoUNIVERSITY OF WASHINGTON — Estrogen across the menstrual cycle for females with inflammatory bowel diseaseUniversity of Washington

    DK grant. $782,361. PI: Kendra Joy Kamp

    full page →nih reporter ↗
    ›Mar 21, 2026grant163d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Clinical Trial Support for the Rutgers Cancer Institute and the RWJBarnabas H...

    CA grant. $975,000. PI: Missak Haigentz

    full page →nih reporter ↗
    ›Mar 22, 2026grant162d agoUT SOUTHWESTERN MEDICAL CENTER — Dissecting the Network Physiology of Pallidal Burst Stimulation

    NS grant. $487,858. PI: Luka Milosevic

    full page →nih reporter ↗

    Week of Mar 23, 2026

    38
    ›Mar 23, 2026approval161d agoKETALAR (KETAMINE HYDROCHLORIDE) — FDA approvalPar Pharmaceutical Inc

    Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 23, 2026approval
    ← prev
    page 453 of 475
    next →
    161d ago
    CLINDAMYCIN PHOSPHATE — FDA approvalCLEOCIN

    Sponsor: RISING. Form: SOLUTION. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›Mar 23, 2026approval161d agoCEFIXIME — FDA approvalCEFIXIME

    Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

    full page →CEFIXIME →fda approvals ↗
    ›Mar 23, 2026approval161d agoCINACALCET HYDROCHLORIDE — FDA approvalCINACALCET HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →CINACALCET HYDROCHLORIDE →fda approvals ↗
    ›Mar 23, 2026approval161d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Mar 23, 2026approval161d agoMEXILETINE HYDROCHLORIDE — FDA approvalMEXILETINE HYDROCHLORIDE

    Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →MEXILETINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 23, 2026approval161d agoMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalatovaquone

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →atovaquone →fda approvals ↗
    ›Mar 23, 2026grant161d agoSTANFORD UNIVERSITY — Center for Definitive and Curative Medicine Annual SymposiumStanford University

    TR grant. $30,000. PI: Matthew H Porteus

    full page →nih reporter ↗
    ›Mar 23, 2026grant161d agoUNIVERSITY OF TEXAS AT AUSTIN — Music-4-MS to Improve Cognition in People Living with Multiple Sclerosis: A F...

    NR grant. $430,884. PI: Carolyn Phillips

    full page →nih reporter ↗
    ›Mar 23, 2026grant161d agoAUBURN UNIVERSITY AT AUBURN — Generalizable quantitative analysis of cell spheroid models and tissues using...

    GM grant. $417,061. PI: Christopher J Easley

    full page →nih reporter ↗
    ›Mar 23, 2026grant161d agoUNIVERSITY OF FLORIDA — Navigating the Uncertainties of Thyroid Cancer Risk in GLP-1RA UsersUniversity of Florida

    CA grant. $694,122. PI: Naykky Singh Ospina

    full page →nih reporter ↗
    ›Mar 23, 2026grant161d agoCOLD SPRING HARBOR LABORATORY — CSHL 2026 Conference on the PARP Family & ADP-Ribosylation

    CA grant. $8,000. PI: DAVID J. STEWART

    full page →nih reporter ↗
    ›Mar 24, 2026approval160d agoBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) — FDA approvalAurobindo Pharma Ltd

    Sponsor: UNIQUE PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval160d agoGUANFACINE HYDROCHLORIDE — FDA approvalGUANFACINE HYDROCHLORIDE

    Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: ORAL

    full page →GUANFACINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval160d agoTICAGRELOR — FDA approvalTICAGRELOR

    Sponsor: ZHEJIANG JINGXIN. Form: TABLET. Route: ORAL

    full page →TICAGRELOR →fda approvals ↗
    ›Mar 24, 2026approval160d agoAVLAYAH (TIVIDENOFUSP ALFA-EKNM) — FDA approvaltividenofusp alfa

    Sponsor: DENALI THERAPEUTICS INC.. Form: INJECTION. Route: POWDER,FOR SOLUTION

    full page →tividenofusp alfa →fda approvals ↗
    ›Mar 24, 2026approval160d agoCHILDREN'S ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approvalKenvue Inc.

    Sponsor: KENVUE BRANDS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval160d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval160d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval160d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval160d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval160d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval160d agoRINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 24, 2026grant160d agoGORDON RESEARCH CONFERENCES — 2026 Cell Death Gordon Research Conference and Gordon Research Seminar

    AI grant. $10,000. PI: Nancy Ryan Gray

    full page →nih reporter ↗
    ›Mar 24, 2026grant160d agoJOHNS HOPKINS UNIVERSITY — The functions of the claustrum in flexible decision making.Johns Hopkins University

    MH grant. $608,086. PI: Solange P Brown

    full page →nih reporter ↗
    ›Mar 24, 2026grant160d agoUNIVERSITY OF MISSOURI-COLUMBIA — Structure-Function Studies of Apolipoprotein B100

    GM grant. $429,797. PI: Zachary T. Berndsen

    full page →nih reporter ↗
    ›Mar 24, 2026grant160d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — From Atoms to Organoids: Understanding the Conformational Landscape and Regul...

    CA grant. $141,566. PI: Fatema Bhinderwala

    full page →nih reporter ↗
    ›Mar 24, 2026grant160d agoUNIVERSITY OF GEORGIA — Calcium Nanoparticles to Enhance Immuno-Radiotherapy

    CA grant. $618,236. PI: Yong Teng

    full page →nih reporter ↗
    ›Mar 24, 2026grant160d agoYALE UNIVERSITY — Leveraging Clinical Data and Automation to Predict Epilepsy After TBI

    NS grant. $722,338. PI: Jennifer A Kim

    full page →nih reporter ↗
    ›Mar 24, 2026grant160d agoDANA-FARBER CANCER INST — TIRR/53BP1 complex regulates mitotic fidelity and immune-mediated radiation r...

    CA grant. $683,075. PI: Dipanjan Chowdhury

    full page →nih reporter ↗
    ›Mar 25, 2026approval159d agoMARINOL (DRONABINOL) — FDA approvalVertanical GmbH

    Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 25, 2026approval159d agoTRETINOIN — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: ENCUBE. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 25, 2026approval159d agoELREXFIO (ELRANATAMAB) — FDA approvalelranatamab

    Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION

    full page →elranatamab →fda approvals ↗
    ›Mar 25, 2026approval159d agoWINREVAIR (SOTATERCEPT-CSRK) — FDA approvalsotatercept

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →sotatercept →fda approvals ↗
    ›Mar 25, 2026approval159d agoLIFYORLI (COPACKAGED) (RELACORILANT) — FDA approvalCORCEPT THERAPEUTICS INC

    Sponsor: CORCEPT THERAP. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 25, 2026approval159d agoKRAZATI (ADAGRASIB) — FDA approvalBristol-Myers Squibb Co

    Sponsor: BRISTOL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 25, 2026approval159d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

    Sponsor: GRANULES. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗
    ›Mar 25, 2026grant159d agoMASSACHUSETTS GENERAL HOSPITAL — Characterizing intracortical feedforward and feedback sensory processes in ASDMassachusetts General Hospital

    MH grant. $824,728. PI: Jyrki Ahveninen

    full page →nih reporter ↗
    $PFE27.96-0.21%
    $CORT113.88-2.61%
    $AMRX17.54-2.61%
    $KVUE19.17-0.16%
    $DNLI24.00-2.72%